Browsing Tag
CNS Clinical Trials
1 post
Tonix Pharmaceuticals stock watch: Is this 28% jump the start of a biotech rebound or a speculative spike?
Tonix Pharmaceuticals stock soared 28% on May 27. Is it a biotech comeback or just a short squeeze? Read the deep dive on TNXP’s pipeline, sentiment, and funding risks.